Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI

Last updated: May 17, 2025
Sponsor: Samsung Medical Center
Overall Status: Completed

Phase

N/A

Condition

Vascular Diseases

Coronary Artery Disease

Atherosclerosis

Treatment

LDL reduction therapy

Clinical Study ID

NCT06338956
Lipid-PCI
  • Ages > 19
  • All Genders

Study Summary

For the management of low-density lipoprotein-cholesterol (LDL-C), some guidelines recommend initial statin treatment with high-intensity statins to achieve at least a 50% reduction in LDL-C levels. High-intensity or maximally tolerated intensity can be maintained without a target goal. However, the European guideline recommends less than 55 mg/dL of LDL-C after PCI.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients receiving PCI with health check up before and after PCI within 3 years

Exclusion

Exclusion Criteria:

  • Patients receiving statin before PCI

  • Patients with liver cirrhosis

  • Patients with cancer

  • Patients without prescription of statin

  • Patients with LDL-C <55 mg/dL before PCI

Study Design

Total Participants: 135877
Treatment Group(s): 1
Primary Treatment: LDL reduction therapy
Phase:
Study Start date:
January 01, 2024
Estimated Completion Date:
May 15, 2025

Study Description

To investigate the Optimal Attained LDL-C Levels in Patients Who Achieved ≥50% LDL-C Reduction After PCI.

Connect with a study center

  • Samsung Medical Center

    Seoul,
    Korea, Republic of

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.